Blue Sphere Health
  • slide-two

    Specialist consultants for serialisation, anti-counterfeiting and mobile health
  • slide-one

  • slide-two

About Blue Sphere

Blue Sphere Health Ltd, (“Bluesphere”) is a rapidly growing consultancy focusing on pharmaceutical security, patient safety and anti-counterfeiting. We also specialise in related issues such as mobile health technology to improve patient outcomes. [Scroll down for more or use the tabs at the top to navigate.]


We combine the deep strategic expertise of a major consultancy with the tactical knowledge and delivery flexibility of a niche specialist.

Bluesphere founder Mark Davison is a world expert on pharmaceutical anti-counterfeiting. He leads an experienced team which advises drug companies, non-governmental organisations (NGOs) and governments on how to keep patients safe from the dangers of falsified medicines. We are leaders in serialisation and the global traceability of medicines. Regulatory requirements for pack coding in the EU, USA, China and elsewhere will impact all pharmaceutical commerce. We will help you to keep ahead of the compliance curve. We also help turn cost into opportunity through intelligent use of coded packs and mobile patient engagement. Let us show you how to find the elusive return on investment for your serialisation initiative. For those of you working in the UK NHS, or supplying to it, we can also help with implementation of mandatory GS1 standards for compliance with NHS eProcurement rules. Please see the rest of the site for more detailed information or contact us now to discuss how we can help you. Find out more Read our blog


If you are designing or reviewing your strategy for brand protection you need to think wider than coding and serialisation.

Find out more


The next few years will see major change in the pharmaceutical supply chain. Traceability is coming to almost all major markets.

Find out more

Patient engagement

Traceability is coming to almost all major pharmaceutical markets. The Falsified Medicine Directive in the European Union, Drug Quality and Safety Act in the USA.

Find out more

Contact Us

Your Name (required)

Your Email (required)


Your Message

Pharmaceutical Anti-Counterfeiting

Combating the Real Danger from Fake Drugs has become a must-have primer on anti-counterfeiting and is widely used by drug companies, regulators and others. The book covers the legal, strategic and political issues as well as the technical counter-measures such as process control, digital serialisation and physical security.

Pharmaceutical Anti-Counterfeiting book